ACM
MRTX

AlphaCrest Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

AlphaCrest Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$610K Buy
2021
Q4 		$793K Buy
2021
Q3 		– Sell
2021
Q2 		$614K Sell
2021
Q1 		$871K Buy
2020
Q4 		$395K Buy
2020
Q2 		– Sell
2020
Q1 		$254K Buy